US Edition3 Articles
3 Articles
As global demand for drugs for weight loss increases sharply, China is about to approve its first dual-target obesity treatment developed nationally. The drug, called mazdutide, is awaiting a marketing authorisation after the success of the local Phase 3 clinical trials and could be launched later this year.
New diabetes treatment may stop daily insulin injections
More than 37 million people in the U.S. live with diabetes, and most of them have type 2 diabetes. Although this condition is more common in older adults, it is increasingly being diagnosed in younger people as well. Managing type 2 diabetes usually requires medication to control blood sugar, and in some cases, patients must […] The post New diabetes treatment may stop daily insulin injections appeared first on Knowridge Science Report.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
